12 Health Care Stocks Moving In Thursday's Pre-Market Session

ADMA Biologics, Inc.
agilon health inc
Accuray Incorporated
Aspire Biopharma Holdings, Inc.
Atara Biotherapeutics Inc

ADMA Biologics, Inc.

ADMA

0.00

agilon health inc

AGL

0.00

Accuray Incorporated

ARAY

0.00

Aspire Biopharma Holdings, Inc.

ASBP

0.00

Atara Biotherapeutics Inc

ATRA

0.00

Gainers

  • Agilon Health (NYSE:AGL) shares moved upwards by 55.6% to $43.33 during Thursday's pre-market session. The company's market cap stands at $463.9 million. The company's, Q1 earnings came out yesterday.
  • Atara Biotherapeutics (NASDAQ:ATRA) stock moved upwards by 40.77% to $7.25. The market value of their outstanding shares is at $43.8 million.
  • Cross Country Healthcare (NASDAQ:CCRN) stock rose 29.08% to $13.05. The company's market cap stands at $325.5 million. As per the press release, Q1 earnings came out today.
  • Aspire Biopharma Holdings (NASDAQ:ASBP) stock increased by 26.72% to $0.24.
  • Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 18.54% to $1.47. The company's market cap stands at $101.1 million.
  • Ernexa Therapeutics (NASDAQ:ERNA) shares moved upwards by 16.55% to $7.04. The market value of their outstanding shares is at $7.0 million.

Losers

  • enGene Therapeutics (NASDAQ:ENGN) shares decreased by 67.5% to $2.88 during Thursday's pre-market session. The company's market cap stands at $592.8 million.
  • Entrada Therapeutics (NASDAQ:TRDA) stock fell 47.6% to $8.4. The market value of their outstanding shares is at $622.2 million.
  • Pharming (NASDAQ:PHAR) shares fell 19.62% to $13.18. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out today.
  • ADMA Biologics (NASDAQ:ADMA) stock declined by 18.86% to $8.18. The market value of their outstanding shares is at $2.3 billion. The company's, Q1 earnings came out yesterday.
  • Accuray (NASDAQ:ARAY) shares decreased by 14.3% to $0.41. The company's market cap stands at $54.0 million. The company's, Q3 earnings came out yesterday.
  • Zoetis (NYSE:ZTS) stock declined by 13.68% to $96.01. The company's market cap stands at $46.9 billion. The company's, Q1 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.